|
1
|
Ding DL, Shen XB, Yu LZ, Zheng YY, Liu Y,
Wang W, Liu L, Zhao ZT, Nian SH and Liu LM: Timosaponin BII
inhibits TGF-β mediated epithelial-mesenchymal transition through
Smad-dependent pathway during pulmonary fibrosis. Phytother Res.
37:2787–2799. 2023.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Zhao T, Zhou Z, Wan H, Feng T, Hu X, Li X,
Zhao S, Li H, Hou J, Li W, et al: Otilonium bromide ameliorates
pulmonary fibrosis in mice through activating phosphatase PPM1A.
Acta Pharmacol Sin: August 19, 2024 (Epub ahead of print).
|
|
3
|
Tu JY, Chen XY, Li CY, Liu CF, Huang YB,
Wang X, Liang H and Yuan XL: Nintedanib mitigates radiation-induced
pulmonary fibrosis by suppressing epithelial cell inflammatory
response and inhibiting fibroblast-to-myofibroblast transition. Int
J Biol Sci. 20:3353–3371. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Confalonieri P, Volpe MC, Jacob J,
Maiocchi S, Salton F, Ruaro B, Confalonieri M and Braga L:
Regeneration or repair? The role of alveolar epithelial cells in
the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cells.
11(2095)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kinoshita T and Goto T: Molecular
mechanisms of pulmonary fibrogenesis and its progression to lung
cancer: A review. Int J Mol Sci. 20(1461)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pu Z, Sui B, Wang X, Wang W, Li L and Xie
H: The effects and mechanisms of the anti-COVID-19 traditional
Chinese medicine, Dehydroandrographolide from Andrographis
paniculata (Burm.f.) Wall, on acute lung injury by the inhibition
of NLRP3-mediated pyroptosis. Phytomedicine.
114(154753)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang H, Hua C, Yang X, Fan X, Song H, Peng
L and Ci X: Pterostilbene prevents LPS-induced early pulmonary
fibrosis by suppressing oxidative stress, inflammation and
apoptosis in vivo. Food Funct. 11:4471–4484. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Otoupalova E, Smith S, Cheng GJ and
Thannickal VJ: Oxidative stress in pulmonary fibrosis. Compr
Physiol. 10:509–547. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Valenca SS, Dong BE, Gordon EM, Sun RC and
Waters CM: ASK1 regulates bleomycin-induced pulmonary fibrosis. Am
J Respir Cell Mol Biol. 66:484–496. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tremayne P and John Clark S: Idiopathic
pulmonary fibrosis: A more common condition than you may think. Br
J Nurs. 30:359–366. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hoyer N, Prior TS, Bendstrup E, Wilcke T
and Shaker SB: Risk factors for diagnostic delay in idiopathic
pulmonary fibrosis. Respir Res. 20(103)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Maher TM, Bendstrup E, Dron L, Langley J,
Smith G, Khalid JM, Patel H and Kreuter M: Global incidence and
prevalence of idiopathic pulmonary fibrosis. Respir Res.
22(197)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Glassberg MK: Overview of idiopathic
pulmonary fibrosis, evidence-based guidelines, and recent
developments in the treatment landscape. Am J Manag Care. 25 (11
Suppl):S195–S203. 2019.PubMed/NCBI
|
|
14
|
Agostini C and Gurrieri C:
Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc
Am Thorac Soc. 3:357–363. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li H, Li Q and Hao Z, Zhang L, Zheng X,
Zhu L, Huo Y, Tian H, He L and Hao Z: A recombinant IL-1β vaccine
attenuates bleomycin-induced pulmonary fibrosis in mice. Vaccine.
42:3774–3788. 2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Park SJ, Ryu HW, Kim JH, Hahn HJ, Jang HJ,
Ko SK, Oh SR and Lee HJ: Daphnetin alleviates bleomycin-induced
pulmonary fibrosis through inhibition of epithelial-to-mesenchymal
transition and IL-17A. Cells. 12(2795)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xu X, Dai W and Li C: Interleukins in the
treatment of melanoma. Chin Med J (Engl). 135:393–399.
2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gritsenko A, Diaz-Pino R and
López-Castejón G: NLRP3 inflammasome triggers interleukin-37
release from human monocytes. Eur J Immunol. 52:1141–1157.
2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fukaura R and Akiyama M: Targeting IL-36
in inflammatory skin diseases. Biodrugs. 37:279–293.
2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bequignon E, Mangin D, Bécaud J, Pasquier
J, Angely C, Bottier M, Escudier E, Isabey D, Filoche M, Louis B,
et al: Pathogenesis of chronic rhinosinusitis with nasal polyps:
Role of IL-6 in airway epithelial cell dysfunction. J Transl Med.
18(136)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mesas-Fernández A, Bodner E, Hilke FJ,
Meier K, Ghoreschi K and Solimani F: Interleukin-21 in autoimmune
and inflammatory skin diseases. Eur J Immunol.
53(e2250075)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Akdis M, Burgler S, Crameri R, Eiwegger T,
Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, et
al: Interleukins, from 1 to 37, and interferon-γ: Receptors,
functions, and roles in diseases. J Allergy Clin Immunol.
127:701–721.e1-e70. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li Y, Yin H, Yuan H, Wang E, Wang C, Li H,
Geng X, Zhang Y and Bai J: IL-10 deficiency aggravates cell
senescence and accelerates BLM-induced pulmonary fibrosis in aged
mice via PTEN/AKT/ERK pathway. BMC Pulm Med. 24(443)2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fattakhov N, Ngo A, Torices S, Joseph JA,
Okoro A, Moore C, Naranjo O, Becker S and Toborek M: Cenicriviroc
prevents dysregulation of astrocyte/endothelial cross talk induced
by ischemia and HIV-1 via inhibiting the NLRP3 inflammasome and
pyroptosis. Am J Physiol Cell Physiol. 326:C487–C504.
2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen P, Zhou J, Ruan AM, Ma YF and Wang
QF: Paeoniflorin, the Main monomer component of paeonia lactiflora,
exhibits anti-inflammatory properties in osteoarthritis synovial
inflammation. Chin J Integr Med. 30:433–442. 2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiong Y, Cui X, Zhou Y, Chai G, Jiang X,
Ge G, Wang Y, Sun H, Che H, Nie Y and Zhao P: Dehydrocostus lactone
inhibits BLM-induced pulmonary fibrosis and inflammation in mice
via the JNK and p38 MAPK-mediated NF-κB signaling pathways. Int
Immunopharmacol. 98(107780)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yan L, Hou C, Liu J, Wang Y, Zeng C, Yu J,
Zhou T, Zhou Q, Duan S and Xiong W: Local administration of
liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis
by modulating macrophage polarization. Sci China Life Sci.
66:2571–2586. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang LM, Zhang Y, Fei C, Zhang J, Wang L,
Yi ZW and Gao G: Neutralization of IL-18 by IL-18 binding protein
ameliorates bleomycin-induced pulmonary fibrosis via inhibition of
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
508:660–666. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu X, Luo S, Li B, Dai H and Zhang J:
IL-25 contributes to lung fibrosis by directly acting on alveolar
epithelial cells and fibroblasts. Exp Biol Med (Maywood).
244:770–780. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nie YJ, Wu SH, Xuan YH and Yan G: Role of
IL-17 family cytokines in the progression of IPF from inflammation
to fibrosis. Mil Med Res. 9(21)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Boersma B, Jiskoot W, Lowe P and Bourquin
C: The interleukin-1 cytokine family members: Role in cancer
pathogenesis and potential therapeutic applications in cancer
immunotherapy. Cytokine Growth Factor Rev. 62:1–14. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Garlanda C and Mantovani A: Interleukin-1
in tumor progression, therapy, and prevention. Cancer Cell.
39:1023–1027. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dinarello CA: Interleukin-1 in the
pathogenesis and treatment of inflammatory diseases. Blood.
117:3720–3732. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dinarello CA: Interleukin-1. Cytokine
Growth Factor Rev. 8:253–265. 1997.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Calverley PM, Sethi S, Dawson M, Ward CK,
Finch DK, Penney M, Newbold P and van der Merwe R: A randomised,
placebo-controlled trial of anti-interleukin-1 receptor 1
monoclonal antibody MEDI8968 in chronic obstructive pulmonary
disease. Respir Res. 18(153)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Grönberg C, Rattik S, Tran-Manh C, Zhou X,
Rius Rigau A, Li YN, Györfi AH, Dickel N, Kunz M, Kreuter A, et al:
Combined inhibition of IL-1, IL-33 and IL-36 signalling by
targeting IL1RAP ameliorates skin and lung fibrosis in preclinical
models of systemic sclerosis. Ann Rheum Dis. 83:1156–1168.
2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang YX, Zhang XT, Li HJ, Zhou TF, Zhou
AC, Zhong ZL, Liu YH, Yuan LL, Zhu HY, Luan D and Tong JC:
Antidepressant-like effects of helicid on a chronic unpredictable
mild stress-induced depression rat model: Inhibiting the
IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation. Int
Immunopharmacol. 93(107165)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li W, Zhao X, Yu TT, Hao W and Wang GG:
Knockout of PKC θ gene attenuates oleic acid-induced acute lung
injury via reduction of inflammation and oxidative stress. Iran J
Basic Med Sci. 24:986–991. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Witzenrath M and Kuebler WM: The
lung-brain axis in ventilator-induced brain injury: Enter IL-6. Am
J Respir Cell Mol Biol. 65:339–340. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jones BE, Maerz MD and Buckner JH: IL-6: A
cytokine at the crossroads of autoimmunity. Curr Opin Immunol.
55:9–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Le TTT, Karmouty-Quintana H, Melicoff E,
Le TTT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, et
al: Blockade of IL-6 trans signaling attenuates pulmonary fibrosis.
J Immunol. 193:3755–3768. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhao FZ, Sang XQ, Zhu Y and Yang J: Effect
and mechanism of IL-6 induced by M2 macrophages on the lung
fibroblasts activation. Acta Pharmaceutica Sinica. 55:892–897.
2020.
|
|
43
|
Yang LB, Herrera J, Gilbertsen AJ, Xia H,
Smith K, Benyumov A, Bitterman PB and Henke CA: IL-8 mediates
idiopathic pulmonary fibrosis mesenchymal progenitor cell
fibrogenicity. Am J Physiol Lung Cell Mol Physiol. 314:L127–L136.
2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Shochet GE, Brook E, Bardenstein-Wald B
and Shitrit D: TGF-β pathway activation by idiopathic pulmonary
fibrosis (IPF) fibroblast derived soluble factors is mediated by
IL-6 trans-signaling. Respir Res. 12(56)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu Y, Lu F, Kang L, Wang Z and Wang Y:
Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice
by regulating Nrf2/Bach1 equilibrium. BMC Pulm Med.
17(63)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cebi M and Yilmaz Y: Immune system
dysregulation in the pathogenesis of non-alcoholic steatohepatitis:
Unveiling the critical role of T and B lymphocytes. Front Immunol.
15(1445634)2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Read J, Reid AT, Thomson C, Plit M, Mejia
R, Knight DA, Lize M, Kasmi KE, Grainge CL, Stahl H and Schuliga M:
Alveolar epithelial cells of lung fibrosis patients are susceptible
to severe virus-induced injury. Clin Sci (Lond). 138:537–554.
2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Jøntvedt Jørgensen M, Holter JC,
Christensen EE, Schjalm C, Tonby K, Pischke SE, Jenum S, Skeie LG,
Nur S, Lind A, et al: Increased interleukin-6 and macrophage
chemoattractant protein-1 are associated with respiratory failure
in COVID-19. Sci Rep. 10(21697)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Khanna D, Lin CJF, Furst DE, Goldin J, Kim
G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, et
al: Tocilizumab in systemic sclerosis: A randomised, double-blind,
placebo-controlled, phase 3 trial. Lancet Respir Med. 8:963–974.
2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Sagaram M, Frimodig J, Jayanty D, Hu H,
Royer AJ, Bruner R, Kong M, Schwandt ML and Vatsalya V: One-month
assessment of Th-cell axis related inflammatory cytokines, IL-17
and IL-22 and their role in alcohol-associated liver disease. Front
Immunol. 14(1202267)2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kosmopoulos M, Christofides A, Drekolias
D, Zavras PD, Gargalionis AN and Piperi C: Critical role of IL-8
targeting in gliomas. Curr Med Chem. 25:1954–1967. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
W.Y. B: Changes of IL-2R, IL-6, IL-8, and
TNF-α in diffuse large B-cell lymphoma and their significance. J
Clin Hematol. 36:33–38. 2023.
|
|
53
|
Papiris SA, Tomos IP, Karakatsani A,
Spathis A, Korbila I, Analitis A, Kolilekas L, Kagouridis K,
Loukides S, Karakitsos P and Manali ED: High levels of IL-6 and
IL-8 characterize early-on idiopathic pulmonary fibrosis acute
exacerbations. Cytokine. 102:168–172. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yang L, Xia H, Gilbertsen A, Smith K,
Racila E, Bitterman PB and Henke CA: IL-8 concurrently promotes
idiopathic pulmonary fibrosis mesenchymal progenitor cell
senescence and PD-L1 expression enabling escape from immune cell
surveillance. Am J Physiol Lung Cell Mol Physiol. 324:L849–L862.
2023.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Li Y, Su G, Zhong Y, Xiong Z, Huang T,
Quan J, Huang J, Wen X, Luo C, Zheng W, et al: HB-EGF-induced IL-8
secretion from airway epithelium leads to lung fibroblast
proliferation and migration. BMC Pulm Med. 21(347)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kato A: Immunopathology of chronic
rhinosinusitis. Allergol Int. 64:121–130. 2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Moonwiriyakit A, Yimnual C, Noitem R,
Dinsuwannakol S, Sontikun J, Kaewin S, Worakajit N,
Soontornniyomkij V and Muanprasat C: GPR120/FFAR4 stimulation
attenuates airway remodeling and suppresses IL-4- and IL-13-induced
airway epithelial injury via inhibition of STAT6 and Akt. Biomed
Pharmacother. 168(115774)2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Iwaszko M, Biały S and Bogunia-Kubik K:
Significance of interleukin (IL)-4 and IL-13 in inflammatory
arthritis. Cells. 10(3000)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Husna SMN, Shukri NM, Ashari NSM and Wong
KK: IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and
asthma. PeerJ. 10(e13444)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Bonser LR, Eckalbar WL, Rodriguez L, Shen
J, Koh KD, Ghias K, Zlock LT, Christenson S, Woodruff PG,
Finkbeiner WE and Erle DJ: The type 2 asthma mediator IL-13
inhibits severe acute respiratory syndrome coronavirus 2 infection
of bronchial epithelium. Am J Respir Cell Mol Biol. 66:391–401.
2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Le Floc'h A, Allinne J, Nagashima K, Scott
G, Birchard D, Asrat S, Bai Y, Lim WK, Martin J, Huang T, et al:
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody,
is required to broadly inhibit type 2 inflammation. Allergy.
75:1188–1204. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Passalacqua G, Mincarini M, Colombo D,
Troisi G, Ferrari M, Bagnasco D, Balbi F, Riccio A and Canonica GW:
IL-13 and idiopathic pulmonary fibrosis: Possible links and new
therapeutic strategies. Pulm Pharmacol Ther. 45:95–100.
2017.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier
CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, et
al: Dupilumab for COPD with type 2 inflammation indicated by
eosinophil counts. N Engl J Med. 389:205–214. 2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Maher TM, Costabel U, Glassberg MK, Kondoh
Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors
M, et al: Phase 2 trial to assess lebrikizumab in patients with
idiopathic pulmonary fibrosis. Eur Respir J.
57(1902442)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Shaikh SB, Prabhu A and Bhandary YP:
Interleukin-17A: A potential therapeutic target in chronic lung
diseases. Endocr Metab Immune Disord Drug Targets. 19:921–928.
2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Berry SPDG, Dossou C, Kashif A,
Sharifinejad N, Azizi G, Hamedifar H, Sabzvari A and Zian Z: The
role of IL-17 and anti-IL-17 agents in the immunopathogenesis and
management of autoimmune and inflammatory diseases. Int
Immunopharmacol. 102(108402)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Yang Z, Zhang J, Zhu Y, Zhang C, Li G, Liu
S, Du J, Han Y and You B: IL-17A induces valvular endothelial
inflammation and aggravates calcific aortic valve disease. Biochem
Biophys Res Commun. 672:145–153. 2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Luo J, An X, Yao Y, Erb C, Ferguson A,
Kolls JK, Fan S and Chen K: Epigenetic regulation of IL-17-induced
chemokines in lung epithelial cells. Mediators Inflamm.
2019(9050965)2019.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lei L, Zhao C, Qin F, He ZY, Wang X and
Zhong XN: Th17 cells and IL-17 promote the skin and lung
inflammation and fibrosis process in a bleomycin-induced murine
model of systemic sclerosis. Clin Exp Rheumatol. 34 (Suppl
100):S14–S22. 2016.PubMed/NCBI
|
|
70
|
Gouda MM and Bhandary YP: Acute lung
injury: IL-17A-mediated inflammatory pathway and its regulation by
curcumin. Inflammation. 42:1160–1169. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Roos AB, Mori M, Gura HK, Lorentz A,
Bjermer L, Hoffmann HJ, Erjefält JS and Stampfli MR: Increased
IL-17RA and IL-17RC in end-stage COPD and the contribution to mast
cell secretion of FGF-2 and VEGF. Respir Res. 18(48)2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Miossec P and Kolls JK: Targeting IL-17
and TH17 cells in chronic inflammation. Nat Rev Drug Discov.
11:763–776. 2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Rex DAB, Dagamajalu S, Gouda MM, Suchitha
GP, Chanderasekaran J, Raju R, Prasad TSK and Bhandary YP: A
comprehensive network map of IL-17A signaling pathway. J Cell
Commun Signal. 17:209–215. 2023.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Schmidt T, Luebbe J, Kilian C, Riedel JH,
Hiekmann S, Asada N, Ginsberg P, Robben L, Song N, Kaffke A, et al:
IL-17 receptor C signaling controls CD4+ TH17
immune responses and tissue injury in immune-mediated kidney
diseases. J Am Soc Nephrol. 32:3081–3098. 2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
He F, Yu X, Zhang J, Cui J, Tang L, Zou S,
Pu J and Ran P: Biomass-related PM2.5 induced
inflammatory microenvironment via IL-17F/IL-17RC axis. Environ
Pollut. 342(123048)2024.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Ni Q, Li G, Chen Y, Bao C, Wang T, Li Y,
Ruan X, Wang H and Sun W: LECs regulate neutrophil clearance
through IL-17RC/CMTM4/NF-κB axis at sites of inflammation or
infection. Mucosal Immunol. 17:723–738. 2024.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Park SJ, Hahn HJ, Oh SR and Lee HJ:
Theophylline attenuates BLM-induced pulmonary fibrosis by
inhibiting Th17 differentiation. Int J Mol Sci.
24(1019)2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Maxwell JR, Yadav R, Rossi RJ, Ruby CE,
Weinberg AD, Aguila HL and Vella AT: IL-18 bridges innate and
adaptive immunity through IFN-gamma and the CD134 pathway. J
Immunol. 177:234–245. 2006.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Shao XF, Li B, Shen J, Wang QF, Chen SS,
Jiang XC and Qiang D: Ghrelin alleviates traumatic brain
injury-induced acute lung injury through pyroptosis/NF-κB pathway.
Int Immunopharmacol. 79(106175)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kobori T, Hamasaki S, Kitaura A, Yamazaki
Y, Nishinaka T, Niwa A, Nakao S, Wake H, Mori S, Yoshino T, et al:
Interleukin-18 amplifies macrophage polarization and morphological
alteration, leading to excessive angiogenesis. Front Immunol.
9(334)2018.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Cai G, Lu Y, Zhong W, Wang T, Li Y, Ruan
X, Chen H, Sun L, Guan Z, Li G, et al: Piezo1-mediated M2
macrophage mechanotransduction enhances bone formation through
secretion and activation of transforming growth factor-β1. Cell
Prolif. 56(e13440)2023.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Zhang C, Zhu X, Hua Y, Zhao Q, Wang K,
Zhen L, Wang G, Lü J, Luo A, Cho WC, et al: YY1 mediates
TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial
cells. Respir Res. 20(249)2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Ibi M, Horie S, Kyakumoto S, Chosa N,
Yoshida M, Kamo M, Ohtsuka M and Ishisaki A: Cell-cell interactions
between monocytes/macrophages and synoviocyte-like cells promote
inflammatory cell infiltration mediated by augmentation of MCP-1
production in temporomandibular joint. Biosci Rep.
38(BSR20171217)2018.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wu L, Pu L and Zhuang Z: miR-155-5p/FOXO3a
promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome
activation. Immunopharmacol Immunotoxicol. 45:257–267.
2023.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Schinocca C, Rizzo C, Fasano S, Grasso G,
La Barbera L, Ciccia F and Guggino G: Role of the IL-23/IL-17
pathway in rheumatic diseases: An overview. Front Immunol.
12(637829)2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Zhang Q, Tong L, Wang B, Wang T and Ma H:
Diagnostic value of serum levels of IL-22, IL-23, and il-17 for
idiopathic pulmonary fibrosis associated with lung cancer. Ther
Clin Risk Manag. 18:429–437. 2022.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Bhattacharya G, Sengupta S, Jha R, Shaw
SK, Jogdand GM, Barink PK, Padhan P, Parida JR and Devadas S:
IL-21/23 axis modulates inflammatory cytokines and RANKL expression
in RA CD4+ T cells via p-Akt1 signaling. Front Immunol.
14(1235514)2023.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Loo WJ, Turchin I, Prajapati VH, Gooderham
MJ, Grewal P, Hong CH, Sauder M, Vender RB, Maari C and Papp KA:
Clinical implications of targeting the JAK-STAT pathway in
psoriatic disease: Emphasis on the TYK2 pathway. J Cutan Med Surg.
27 (1 Suppl):3S–24S. 2023.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Vuyyuru SK, Shackelton LM, Hanzel J, Ma C,
Jairath V and Feagan BG: Targeting IL-23 for IBD: Rationale and
progress to date. Drugs. 83:873–891. 2023.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Ogishi M, Arias AA, Yang R, Han JE, Zhang
P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, et al:
Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial
disease in patients with inherited TYK2 deficiency. J Exp Med.
219(e20220094)2022.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Senoo S, Taniguchi A, Itano J, Oda N,
Morichika D, Fujii U, Guo L, Sunami R, Kanehiro A, Tokioka F, et
al: Essential role of IL-23 in the development of acute
exacerbation of pulmonary fibrosis. Am J Physiol Lung Cell Mol
Physiol. 321:L925–L940. 2021.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Sanada S, Hakuno D, Higgins LJ, Schreiter
ER, McKenzie ANJ and Lee RT: IL-33 and ST2 comprise a critical
biomechanically induced and cardioprotective signaling system. J
Clin Invest. 117:1538–1549. 2007.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Piyadasa H, Lloyd D, Lee AHY, Altieri A,
Hemshekhar M, Osawa N, Basu S, Blimkie T, Falsafi R, Halayko AJ, et
al: Characterization of immune responses and the lung transcriptome
in a murine model of IL-33 challenge. Biochim Biophys Acta Mol
Basis Dis. 1866(165950)2020.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Drake LY and Kita H: IL-33: Biological
properties, functions, and roles in airway disease. Immunol Rev.
278:173–184. 2017.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Chen YL, Gutowska-Owsiak D, Hardman CS,
Westmoreland M, MacKenzie T, Cifuentes L, Waithe D, Lloyd-Lavery A,
Marquette A, Londei M and Ogg C: Proof-of-concept clinical trial of
etokimab shows a key role for IL-33 in atopic dermatitis
pathogenesis. Sci Transl Med. 11(eaax2945)2019.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Kosloski MP, Kalliolias GD, Xu CR, Harel
S, Lai CH, Zheng W, Davis JD and Kamal MA: Pharmacokinetics and
pharmacodynamics of itepekimab in healthy adults and patients with
asthma: Phase I first-in-human and first-in-patient trials. Clin
Transl Sci. 15:384–395. 2022.PubMed/NCBI View Article : Google Scholar
|
|
97
|
She YX, Yu QY and Tang XX: Role of
interleukins in the pathogenesis of pulmonary fibrosis. Cell Death
Discov. 7(52)2021.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Jayalatha AS, Hesse L, Ketelaar ME,
Koppelman GH and Nawijn MC: The central role of IL-33/IL-1RL1
pathway in asthma: From pathogenesis to intervention. Pharmacol
Ther. 225(107847)2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Nechama M, Kwon J, Wei S, Kyi AT, Welner
RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, et al:
The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in
IL-33-induced allergic airway inflammation. Nat Commun.
9(1603)2018.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Reid F, Singh D, Albayaty M, Moate R,
Jimenez E, Sadiq MW, Howe D, Gavala M, Killick H, Williams A, et
al: A randomized phase I study of the anti-interleukin-33 antibody
Tozorakimab in healthy adults and patients with chronic obstructive
pulmonary disease. Clin Pharmacol Ther. 115:565–575.
2024.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Catalan-Dibene J, McIntyre LL and Zlotnik
A: Interleukin 30 to interleukin 40. J Interferon Cytokine Res.
38:423–439. 2018.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Borthwick LA: The IL-1 cytokine family and
its role in inflammation and fibrosis in the lung. Semin
Immunopathol. 38:517–534. 2016.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Andoh A and Nishida A: Pro- and
anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in
inflammatory bowel disease. J Gastroenterol. 58:69–78.
2023.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Aoyagi T, Newstead MW, Zeng XY, Kunkel SL,
Kaku M and Standiford TJ: IL-36 receptor deletion attenuates lung
injury and decreases mortality in murine influenza pneumonia.
Mucosal Immunol. 10:1043–1055. 2017.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Vigne S, Palmer G, Lamacchia C, Martin P,
Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE
and Gabay C: IL-36R ligands are potent regulators of dendritic and
T cells. Blood. 118:5813–5823. 2011.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Cao J, Liu JH, Wise SG, Fan J, Bao S and
Zheng GS: The role of IL-36 and 37 in hepatocellular carcinoma.
Front Immunol. 15(1281121)2024.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Elias M, Zhao S, Le HT, Wang J, Neurath
MF, Neufert C, Fiocchi C and Rieder F: IL-36 in chronic
inflammation and fibrosis-bridging the gap? J Clin Invest.
131(144336)2021.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Montero-Blay A, Blanco JD, Rodriguez-Arce
I, Lastrucci C, Piñero-Lambea C, Lluch-Senar M and Serrano L:
Bacterial expression of a designed single-chain IL-10 prevents
severe lung inflammation. Mol Syst Biol. 19(e11037)2023.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Huaux F: Interpreting immunoregulation in
lung fibrosis: A new branch of the immune model. Front Immunol.
12(690375)2021.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Gabryšová L, Howes A, Saraiva M and
O'Garra A: The regulation of IL-10 expression. Curr Top Microbiol
Immunol. 380:157–190. 2014.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Saraiva M, Vieira P and O'garra A: Biology
and therapeutic potential of interleukin-10. J Exp Med.
217(e20190418)2020.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Chlastáková A, Kaščáková B, Kotál J,
Langhansová H, Kotsyfakis M, Kutá Smatanová I, Tirloni L and
Chmelař J: Iripin-1, a new anti-inflammatory tick serpin, inhibits
leukocyte recruitment in vivo while altering the levels of
chemokines and adhesion molecules. Front Immunol.
14(1116324)2023.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Neumann C, Scheffold A and Rutz S:
Functions and regulation of T cell-derived interleukin-10. Semin
Immunol. 44(101344)2019.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Zhang N, Li P, Lin H, Shuo T, Ping F, Su L
and Chen G: IL-10 ameliorates PM2.5-induced lung injury by
activating the AMPK/SIRT1/PGC-1α pathway. Environ Toxicol
Pharmacol. 86(103659)2021.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Jia Q, Wen J, Yang Q, Liu S, Zhang J, Wang
T and Cheng Y: Lonicera japonica Thunb extract ameliorates
lipopolysaccharide-induced acute lung injury associated with
luteolin-mediated suppression of NF-κB signaling pathway. J Inflamm
(Lond). 20(44)2023.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Boonyatecha N, Sangphech N, Wongchana W,
Kueanjinda P and Palaga T: Involvement of Notch signaling pathway
in regulating IL-12 expression via c-Rel in activated macrophages.
Mol Immunol. 51:255–262. 2012.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Utsunomiya T, Mimura-Kimura Y, Yamamoto T,
Aoe K, Oishi K, Kamei H, Matsunaga K, Yano M and Mimura Y: Cytokine
adsorption to polymyxin B-immobilized fiber: An in vitro study.
Blood Purif. 50:230–237. 2021.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Zhou L, Tian H, Wang Q, Xiong W, Zhou X
and Yan J: Effect of Qingfei Huaxian Decoction combined with
prednisone acetate on serum inflammatory factors and pulmonary
function of patients with idiopathic pulmonary fibrosis. Am J
Transl Res. 14:5905–5914. 2022.PubMed/NCBI
|
|
119
|
Kotani T, Masutani R, Suzuka T, Oda K,
Makino S and Ii M: Anti-inflammatory and anti-fibrotic effects of
intravenous adipose-derived stem cell transplantation in a mouse
model of bleomycin-induced interstitial pneumonia. Sci Rep.
7(14608)2017.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Bao L, Hao CF, Liu SN, Zhang L, Wang J,
Wang D, Li YP and Yao W: Dendritic cells trigger imbalance of
Th1/Th2 cells in silica dust exposure rat model via MHC-II, CD80,
CD86 and IL-12. RSC Adv. 8:26108–26115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Keane MP, Belperio JA, Burdick MD and
Strieter RM: IL-12 attenuates bleomycin-induced pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 281:L92–L97. 2001.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Nie Y, Yang B, Hu J, Zhang L and Ma Z:
Bruceine D ameliorates the balance of Th1/Th2 in a mouse model of
ovalbumin-induced allergic asthma via inhibiting the NOTCH pathway.
Allergol Immunopathol (Madr). 49:73–79. 2021.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Kikuchi N, Ishii Y, Morishima Y, Yageta Y,
Haraguchi N, Itoh K, Yamamoto M and Hizawa N: Nrf2 protects against
pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2
balance. Respir Res. 11(31)2010.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Huaux F, Lardot C, Arras M, Delos M, Many
MC, Coutelier JP, Buchet JP, Renauld JC and Lison D: Lung fibrosis
induced by silica particles in NMRI mice is associated with an
upregulation of the p40 subunit of interleukin-12 and Th-2
manifestations. Am J Respir Cell Mol Biol. 20:561–672.
1999.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Wang XY, Liu DY, Zhang XH, Yang LM, Xia ZY
and Zhang QF: Exosomes from adipose-derived mesenchymal stem cells
alleviate sepsis-induced lung injury in mice by inhibiting the
secretion of IL-27 in macrophages. Cell Death Discov.
8(18)2022.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Chen Y, Zhu M, Hu J, He S, Li S, Liu B and
Yang J: IL-27 alleviates airway inflammation and airway
hyperresponsiveness in asthmatic mice by targeting the CD39/ATP
axis of dendritic cells. Inflammation. 47:807–821. 2024.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Dong Z, Zhao X, Tai W, Lei W, Wang Y, Li Z
and Zhang T: IL-27 attenuates the TGF-β1-induced proliferation,
differentiation and collagen synthesis in lung fibroblasts. Life
Sci. 146:24–33. 2016.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Dong Z, Tai W, Lei W, Wang Y, Li Z and
Zhang T: IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal
transition in alveolar epithelial cells. BMC Cell Biol.
17(7)2016.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Ting L, Feng Y, Zhou Y, Tong Z and Dong Z:
IL-27 induces autophagy through regulation of the DNMT1/lncRNA
MEG3/ERK/p38 axis to reduce pulmonary fibrosis. Respir Res.
24(67)2023.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Riehl DR, Sharma A, Roewe J, Murke F,
Ruppert C, Eming SA, Bopp T, Kleinert H, Radsak MP, Colucci G, et
al: Externalized histones fuel pulmonary fibrosis via a
platelet-macrophage circuit of TGFβ1 and IL-27. Proc Natl Acad Sci
USA. 120(e2215421120)2023.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Dinarello CA and Bufler P: Interleukin-37.
Semin Immunol. 25:466–468. 2013.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Kim SK, Choe JY, Kim JW, Park KY and Kim
B: Anti-inflammatory effect of atorvastatin and rosuvastatin on
monosodium urate-induced inflammation through IL-37/Smad3-complex
activation in an in vitro study using THP-1 macrophages.
Pharmaceuticals (Basel). 17(883)2024.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Luo C, Shu Y, Luo J, Liu D, Huang DS, Han
Y, Chen C, Li YC, Zou JM, Qin J, et al: Intracellular IL-37b
interacts with Smad3 to suppress multiple signaling pathways and
the metastatic phenotype of tumor cells. Oncogene. 36:2889–2899.
2017.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Conti P, Caraffa A, Gallenga CE, Ross R,
Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G and Pandolfi
F: Powerful anti-inflammatory action of luteolin: Potential
increase with IL-38. Biofactors. 47:165–169. 2021.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Diaz-Barreiro A, Huard A and Palmer G:
Multifaceted roles of IL-38 in inflammation and cancer. Cytokine.
151(155808)2022.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Chen W, Xi S, Ke Y and Lei Y: The emerging
role of IL-38 in diseases: A comprehensive review. Immun Inflamm
Dis. 11(e991)2023.PubMed/NCBI View Article : Google Scholar
|
|
137
|
van de Veerdonk FL, de Graaf DM, Joosten
LA and Dinarello CA: Biology of IL-38 and its role in disease.
Immunol Rev. 281:191–196. 2018.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Xu Z, Yuan X, Gao Q, Li Y and Li M:
Interleukin-38 overexpression prevents bleomycin-induced mouse
pulmonary fibrosis. Naunyn Schmiedebergs Arch Pharmacol.
394:391–399. 2021.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Kelly-Welch A, Hanson EM and Keegan AD:
Interleukin-4 (IL-4) pathway. Sci STKE. 2005(cm9)2005.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Rao LZ, Wang Y, Zhang L, Wu G, Zhang L,
Wang FX, Chen LM, Sun F, Jia S, Zhang S, et al: IL-24 deficiency
protects mice against bleomycin-induced pulmonary fibrosis by
repressing IL-4-induced M2 program in macrophages. Cell Death
Differ. 28:1270–1283. 2021.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Sterclova M, Kishore A, Sikorova K,
Skibova J, Petrek M and Vasakova M: Effect of genotype on the
disease course in idiopathic pulmonary fibrosis despite
antifibrotic treatment. Biomed Rep. 15(87)2021.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Singh B, Kasam RK, Sontake V, Wynn TA and
Madala SK: Repetitive intradermal bleomycin injections evoke
T-helper cell 2 cytokine-driven pulmonary fibrosis. Am J Physiol
Lung Cell Mol Physiol. 313:L796–L806. 2017.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Mattoo H, Bangari DS, Cummings S, Humulock
Z, Habiel D, Xu EY, Pate N, Resnick R, Savova V, Qian G, et al:
Molecular features and stages of pulmonary fibrosis driven by type
2 inflammation. Am J Respir Cell Mol Biol. 69:404–421.
2023.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Khansalar S, Faghih Z, Barani S, Kalani M,
Ataollahi MR, Mohammadi Z, Namdari S and Kalantar K: IFN-γ, IL-17,
IL-22+ CD4+ subset in patients with hepatitis
C virus and correlation with clinical factor. Am J Clin Exp
Immunol. 13:43–52. 2024.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Liang M, Wang J, Chu H, Zhu X, He H, Liu
Q, Qiu J, Zhou X, Guan M, Xue Y, et al: Interleukin-22 inhibits
bleomycin-induced pulmonary fibrosis. Mediators Inflamm.
2013(209179)2013.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Bao A, Ma E, Cornman H, Kambala A,
Manjunath J, Kollhoff AL, Imo BU, Kwatra MM and Kwatra SG:
Dupilumab therapy modulates circulating inflammatory mediators in
patients with prurigo nodularis. JID Innov.
4(100281)2024.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Liu J, Huang Y, Liu N, Qiu H, Zhang X, Liu
X, He M, Chen M and Huang S: The imbalance of pulmonary Th17/Treg
cells in BALB/c suckling mice infected with respiratory syncytial
virus-mediated intestinal immune damage and gut microbiota changes.
Microbiol Spectr. 12(e0328323)2024.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Li C, Liu M, Deng L, Luo D, Ma R and Lu Q:
Oxyberberine ameliorates TNBS-induced colitis in rats through
suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB
signaling pathways. Phytomedicine. 116(154899)2023.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Zhang J, Wang W, Liang S, Zhou X, Rekha
RS, Gudmundsson GH, Bergman P, Ai Q, Mai K and Wan M: Butyrate
induces STAT3/HIF-1α/IL-22 signaling via GPCR and HDAC3 inhibition
to activate autophagy in head kidney macrophages from turbot
(Scophthalmus maximus L.). Fish Shellfish Immunol.
143(109214)2023.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Sajiir H, Keshvari S, Wong KY, Borg DJ,
Steyn FJ, Fercher C, Taylor K, Taylor B, Barnard RT, Müller A, et
al: Liver and pancreatic-targeted interleukin-22 as a therapeutic
for metabolic dysfunction-associated steatohepatitis. Nat Commun.
15(4528)2024.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Kamata K, Hara A, Minaga K, Yoshikawa T,
Kurimoto M, Sekai I, Okai N, Omaru N, Masuta Y, Otsuka Y, et al:
Activation of the aryl hydrocarbon receptor inhibits the
development of experimental autoimmune pancreatitis through
IL-22-mediated signaling pathways. Clin Exp Immunol. 212:171–183.
2023.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Zhang Z, Chakawa MB, Galeas-Pena M,
Frydman JA, Allen MJ, Jones M and Pociask D: IL-22 binding protein
controls IL-22-driven bleomycin-induced lung injury. Am J Pathol.
194:338–352. 2024.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Goulart A, Boko MMM, Martins NS, Gembre
AF, de Oliveira RS, Palma-Albornoz SP, Bertolini T, Ribolla PEM,
Ramalho LNZ, Fraga-Silva TFC and Bonato VLD: IL-22 is deleterious
along with IL-17 in allergic asthma but is not detrimental in the
comorbidity asthma and acute pneumonia. Int J Mol Sci.
24(10418)2023.PubMed/NCBI View Article : Google Scholar
|
|
154
|
He G, Lang Y, Zhao S, Wang X and Ouyang Y:
Advances in the role of interleukin-22 in airway remodeling in
asthma. J Pract Med. 38:2491–2494. 2022.
|
|
155
|
Nikoopour E, Bellemore SM and Singh B:
IL-22, cell regeneration and autoimmunity. Cytokine. 74:35–42.
2015.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Zindl CL, Wilson CG, Chadha AS, Duck LW,
Cai B, Harbour SN, Nagaoka-Kamata Y, Hatton RD, Gao M, Figge DA and
Weaver CT: Distal colonocytes targeted by C. rodentium recruit
T-cell help for barrier defence. Nature. 629:669–678.
2024.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Whittington HA, Armstrong L, Uppington KM
and Millar AB: Interleukin-22: A potential immunomodulatory
molecule in the lung. Am J Respir Cell Mol Biol. 31:220–226.
2004.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Zhang C, Tang S, Zong X, Duan L and Wang
YF: Anti- IL-22 neutralizing antibodies decrease inflammation
lesions and reduce mortality in enterovirus 71-infected mice. Cell
Mol Biol (Noisy-le-grand). 69:254–258. 2023.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Qu Z, Dou W, Zhang K, Duan L, Zhou D and
Yin S: IL-22 inhibits bleomycin-induced pulmonary fibrosis in
association with inhibition of IL-17A in mice. Arthritis Res Ther.
24(280)2022.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Gu P, Wang D, Zhang J, Wang X, Chen Z, Gu
L, Liu M, Meng F, Yang J, Cai H, et al: Protective function of
interleukin-22 in pulmonary fibrosis. Clin Transl Med.
11(e509)2021.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Fang S, Ju DW, Lin Y and Chen W: The role
of interleukin-22 in lung health and its therapeutic potential for
COVID-19. Front Immunol. 13(951107)2022.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Fang Q, Xie J, Zong J, Zhou Y, Zhou Q, Yin
S, Cao L, Yin H and Zhou D: Expression and diagnostic value of
interleukin-22 in rheumatoid arthritis-associated interstitial lung
disease. Int Immunopharmacol. 134(112173)2024.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Wu Y, Min J, Ge C, Shu JP, Tian D, Yuan Y
and Zhou D: Interleukin 22 in liver injury, inflammation and
cancer. Int J Biol Sci. 16(2405)2020.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Beppu AK, Zhao J, Yao C, Carraro G,
Israely E, Coelho AL, Drake K, Hogaboam CM, Parks WC, Kolls JK and
Stripp BR: Epithelial plasticity and innate immune activation
promote lung tissue remodeling following respiratory viral
infection. Nat Commun. 14(5814)2023.PubMed/NCBI View Article : Google Scholar
|
